Firms
InnovaHealth Partners
New York, United States
InnovaHealth Partners, LP is a New York medical-technology private equity firm founded in 2016 according to its own company profile. Its principals previously invested at HealthpointCapital, a distinct predecessor business. The current public directory lists eight firm members and nine Strategic Advisors, with founders Mortimer Berkowitz III and John McCormick, Senior Partners Toby Cosgrove and Richard B. Emmitt, and Senior Advisor Ariella Golomb. Its neuroscience and deep-technology exposure includes Monteris Medical’s robotically controlled MRI-guided laser system for brain tumors and epilepsy, Route92Medical’s neurovascular thrombectomy technology, and image-guided or automated medical systems from Koelis and Radiaction. InnovaHealth led Monteris’ actual USD35M Series D equity financing announced in October 2022 and was a current lead investor named in its USD28M Series E announcement in March 2026; separate debt facilities are not InnovaHealth equity checks. Verified InnovaHealth participations are also linked to Route92Medical’s actual 2021 Series E, 2023 Series F, 2024 additional Series F extension and 2026 growth financings, preserving existing round IDs and personal investment history. Its website reports USD290M of assets across funds and co-investments, which is not a closed fund size. Sixteen actual legal private-fund and co-investment vehicles are supported by SEC Form ADV; exact closed sizes and closing dates remain undisclosed. Historical predecessor investments and outside advisory affiliations are separately qualified.
- Founded
- 2016
- Type
- Venture capital
Funds16
Team
Operations and support
 Aileen StockburgerStrategic Advisor (published affiliation) |
 Ariella GolombSenior Advisor |
 Emme DelandStrategic Advisor (published affiliation) |
François des NoyersStrategic Advisor (published affiliation) |
Guy de PanafieuStrategic Advisor (published affiliation) |
 John McCormickPartner and Founder |
 Lisa GranickStrategic Advisor (published affiliation) |
 Mortimer Berkowitz IIIManaging Partner and Founder |
Natalia StrickerExecutive Assistant |
Noah PerelesAssociate |
 Patrick MilesStrategic Advisor (published affiliation) |
 Richard EmmittSenior Partner |
 Thomas KeanStrategic Advisor (published affiliation) |
Tiffany CheynierSenior Manager - Investor Relations and Marketing |
 Toby CosgroveSenior Partner |
 Tony ChouStrategic Advisor (published affiliation) |
 Yves-André IstelStrategic Advisor (published affiliation) |
Co-investing
Casper de Clercq
Route 92 Medical$50M · 2026-04-07- Route 92 Medical$50M · 2024-09-23
- Route 92 Medical$31M · 2023-11-16
- Route 92 Medical$56M · 2021-12-14
Norwest Venture Partners- Route 92 Medical$50M · 2026-04-07
- Route 92 Medical$50M · 2024-09-23
- Route 92 Medical$31M · 2023-11-16
- Route 92 Medical$56M · 2021-12-14
The Vertical Group- Route 92 Medical$50M · 2026-04-07
- Route 92 Medical$50M · 2024-09-23
- Route 92 Medical$31M · 2023-11-16
- Route 92 Medical$56M · 2021-12-14
U.S. Venture Partners- Route 92 Medical$50M · 2026-04-07
- Route 92 Medical$50M · 2024-09-23
- Route 92 Medical$31M · 2023-11-16
- Route 92 Medical$56M · 2021-12-14
Birchview Capital
Monteris Medical$28M · 2026-03-12- Monteris Medical$35M · 2022-10-27
Novo Holdings- Route 92 Medical$50M · 2026-04-07
- Route 92 Medical$50M · 2024-09-23
CU Healthcare Innovation Fund- Monteris Medical$28M · 2026-03-12
Madryn Asset Management- Monteris Medical$28M · 2026-03-12
OSF Ventures- Monteris Medical$28M · 2026-03-12
Sectoral Asset Management- Route 92 Medical$50M · 2026-04-07